Condition
Caesarean Scar Pregnancy
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07288307Phase 2Not Yet RecruitingPrimary
Surgical Evacuation Versus Methotrexate Injection in Treatment of Caesarean Scar Pregnancy [Clinical Trial ]
NCT06276790CompletedPrimary
Objective Analysis of Caesarean Scar Pregnancy
NCT02357095Not ApplicableCompletedPrimary
UACE Followed by Uterine Suction Curettage for the Treatment of Caesarean Scar Pregnancy
NCT01916746Not ApplicableUnknownPrimary
Treatment of Caesarean Scar Pregnancy
Showing all 4 trials